Marketing

Anthem joins insurer-backed generics effort CivicaScript

The subsidiary of hospital-owned nonprofit CivicaRx plans to make six to 10 common generic drugs that don't have enough competition to drive down cost.

By Rebecca Pifer • June 16, 2021

Sponsored by 81qd

Clinical leadership: A foundational double attack strategy

We define the most influential clinicians as Clinical Leaders, those who measurably impact the clinical behavior of other clinicians in their "clinical networks."

Deep Dive

A first-of-its-kind Alzheimer's drug raises heavy questions around who will and won't get it

Biogen priced its newly approved medicine Aduhelm at an average cost of $56,000 a year, adding affordability to other barriers patients may face. 

By Jacob Bell • June 08, 2021

Sponsored by IQVIA

Moving pharma marketing from multichannel to omnichannel

IQVIA experts weigh in on the importance of an omnichannel approach.

FDA restricts use of Intercept drug due to liver injury risk

An investigation linked the drug to severe injuries in about two dozen patients, leading the agency to add a new contraindication to the label.

By Kristin Jensen • May 27, 2021

ICER, vocal critic of drug company pricing, turns scrutiny to insurers

The watchdog group plans to examine how cost sharing can hurt access to care, but it won't assess some of the most controversial insurer practices.

By Jonathan Gardner • May 25, 2021

Pfizer, BioNTech to send EU up to 1.8B coronavirus vaccine doses

The deal, which the companies and the bloc have been negotiating for weeks, will significantly expand on the current contract for 600 million shots.

By Kristin Jensen • May 20, 2021

Humira patents take center stage as House panel targets AbbVie pricing

CEO Richard Gonzalez defended the company's practices, arguing its profits help spur innovation: "The products that are on the market today pay for the products of the future," he said.

By Jonathan Gardner • May 18, 2021

Sponsored by FedEx Office

6 tips to deliver information that matters using print communications

As remote work continues, print is as important as ever for biopharmaceutical companies when it comes to reaching a varied audience that may include patients, doctors' offices, researchers, and internal staff.

Sponsored by IQVIA

Top customer engagement trends in pharma

The future of provider and patient engagement in healthcare.

CDC panel endorses Pfizer vaccine for 12- to 15-year-olds

The vote, which the CDC officially adopted hours after, gives a clear green light for states to begin vaccinating younger adolescents with the shot. 

By Ned Pagliarulo • UPDATED: May 13, 2021 at 10:01 a.m.

Amgen asks FDA for approval of key asthma drug

Tezepelumab is one of Amgen's top experimental medicines and a U.S. OK would help its efforts to offset revenue declines from its aging blockbusters.

By Ned Pagliarulo • May 10, 2021

FDA, CDC support resuming use of J&J vaccine after advisory panel vote

While health officials have documented more cases of a rare blood clotting syndrome associated with J&J's vaccine, a CDC committee supported use of the shot with an added warning. 

By Ned Pagliarulo , Ben Fidler • UPDATED: April 23, 2021 at 7:14 p.m.

Sponsored by Veeva Crossix

A year with COVID-19: The impact of data on pharma marketing

Learn how three pharma brands used data to validate and adjust their promotional spend in 2020.

Biden administration hikes Medicare reimbursement for coronavirus vaccines

The increased payout by Medicare is intended to speed up distribution of the three currently available shots.

By Shannon Muchmore • March 16, 2021

Sponsored by Fyllo

The essential audience for well-being

For marketers in the health space, cannabis and CBD consumers represent an audience that is in search of both alternative and conventional methods of well-being as their transformation from patient to participant accelerates. 

Novavax broadens reach of global coronavirus vaccine alliance with new deal

As more transmissible variants spread across the globe, there's growing urgency to equitably allocate vaccine supplies. A deal between Novavax and COVAX will significantly bolster that effort.

By Ben Fidler • Feb. 19, 2021

Sponsored by IQVIA

Personalize your omnichannel marketing today and see the benefits tomorrow

With virtual interactions here to stay, it's important that pharma marketers continue to embrace the digital world. Learn how a personalized, insights-led approach to marketing drives results.

Pfizer, BioNTech win EU vaccine approval as UK grapples with new coronavirus variant

In a press conference on the authorization, BioNTech CEO Ugur Sahin expressed confidence the vaccine would protect against the emerging virus variant in the U.K.

By Ned Pagliarulo • Dec. 22, 2020

Sponsored by IQVIA

The role of optimized omnichannel marketing in a challenging environment

How can pharma marketers overcome today's cost-constrained, competitive environment?

Hospitals start coronavirus vaccinations in sweeping, nationwide effort

A New York nurse was among the first to get the shot after FDA authorization last week. Many other health systems are either preparing to receive supplies or are already beginning immunizations.

By Samantha Liss • Dec. 14, 2020

UK drug regulator is first to clear Pfizer, BioNTech's coronavirus vaccine

The approval is a notable milestone in the historic pursuit of a protective shot for COVID-19. The two drugmakers plan to ship the first doses within days.

By Jonathan Gardner • Dec. 02, 2020

CDC panel recommends giving first coronavirus vaccines to healthcare workers, nursing home residents

Advisers on the CDC panel cited risk and disease burden as reasons for setting their priority list for the first vaccine doses to become available, supply of which will be extremely limited.

By Jonathan Gardner • Dec. 01, 2020

Hospitals scramble to get ready for coronavirus vaccines

Facilities are preparing ultra-cold storage capabilities and reviewing security plans as they brace for their role in distributing potentially multiple shots.

By Shannon Muchmore • Nov. 19, 2020

As US cases surge, FDA clears first fully at-home COVID-19 test

The prescription test from Lucira Health can deliver results within 30 minutes, and could help boost U.S. testing capacity. Some experts, however, called for more guidance on proper use.

By Greg Slabodkin • Nov. 18, 2020